Patent · US Active

Ether derivatives

US7432291B2 · kind B2 · utility

2Cited by

2References

17Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Birgit Bossenmaier · Hanerau-Hademarschen, DE
Walter-Gunar Friebe · Mannheim, DE
Thomas Friess · Planegg, DE
Ulrike Reiff · Penzberg, DE
Edgar Voss · Bichl, DE

Key dates

Filing date	Mar 17, 2005
Grant date	Oct 7, 2008
Priority date	—
Expiry date	Aug 15, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides the compounds of formula (I)their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.